Latest filing published 19 Mar 2018 for Neurogene Inc., €11k.
Filing timeline
BuySaleInsider track record
Lloyd MacKenzie: trading record in brief
This profile gathers the share dealings of Lloyd MacKenzie in Neurogene Inc. In total, 5 filings cover trades dated from 12 August 2015 to 15 March 2018.
On the market, this insider has only sold: 2 sales, €616k in total. The rest of the record consists of 3 option exercises. Since January 2018: no purchases and 1 sale on the market.
Most recently, on 19 March 2018, the filings show an option exercise worth €11k in Neurogene Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Lloyd MacKenzie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,302 shares@ US$10.5641.9% of flowCommon StockSEC:0001209191-18-020680:0
- 1,302 shares@ US$14.6358.1% of flowCommon StockSEC:0001209191-18-020680:1
- 7,812 shares@ US$5.76Common StockSEC:0001209191-15-066178:0
- 28,075 shares@ US$5.76Common StockSEC:0001209191-15-066178:1
- 35,887 shares@ US$18.67Common StockSEC:0001209191-15-066178:2
5 of 5 declarations